ACULYS is tackling neurological disease in Japan
At ACULYS, our innovative medicines are transforming the field of neurology in Japan — improving the lives of patients and families affected by these complex diseases.
ACULYS Features
Singular focus on neurology
We are a clinical stage biopharmaceutical company focused on neurological diseases, where there is a high unmet medical need.
Accelerating delivery for innovative treatments and medical means
At ACULYS, we’re breaking down barriers to bring innovative neurological treatments to Japan, faster. By focusing on medicines already approved in other countries, we’re cutting through Japan’s drug lag and delivering life-changing therapies to patients and families who need them.
Outstanding knowledge and dedication
Our experienced team, who have contributed to the growth of major global pharmaceutical companies, are combining their knowledge and expertise to achieve our mission of addressing the stigmas and social issues related to neurological diseases.
Recent News
Origin of company name
ACULYS serves the unmet needs of patients in Japan through
improved access to innovative neurological treatments.
